HDAC2 and chronic myelogenous leukemia, BCR-ABL1 positive: To examine the underlying mechanism regarding the synergy of CAY10683 combined with IM in the cell cycle distribution of CML cells resistant to IM, it was hypothesized that HDAC2 over-expression might reduce the cell cycle arrest in the G2/M phase of CML cells resistant to IM.